343 related articles for article (PubMed ID: 31664964)
1. Current state of evidence of cannabis utilization for treatment of autism spectrum disorders.
Agarwal R; Burke SL; Maddux M
BMC Psychiatry; 2019 Oct; 19(1):328. PubMed ID: 31664964
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Cannabidiol-Rich Cannabis in Children with Autism Spectrum Disorder and Severe Behavioral Problems-A Retrospective Feasibility Study.
Aran A; Cassuto H; Lubotzky A; Wattad N; Hazan E
J Autism Dev Disord; 2019 Mar; 49(3):1284-1288. PubMed ID: 30382443
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications.
Holdman R; Vigil D; Robinson K; Shah P; Contreras AE
Cannabis Cannabinoid Res; 2022 Aug; 7(4):451-463. PubMed ID: 34432543
[No Abstract] [Full Text] [Related]
4. Cannabis and cannabinoid use in autism spectrum disorder: a systematic review.
Silva EAD; Medeiros WMB; Torro N; Sousa JMM; Almeida IBCM; Costa FBD; Pontes KM; Nunes ELG; Rosa MDD; Albuquerque KLGD
Trends Psychiatry Psychother; 2022 Jun; 44():e20200149. PubMed ID: 34043900
[TBL] [Abstract][Full Text] [Related]
5. Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review.
Fletcher S; Pawliuk C; Ip A; Huh L; Rassekh SR; Oberlander TF; Siden H
Child Care Health Dev; 2022 Jan; 48(1):33-44. PubMed ID: 34403168
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid treatment for autism: a proof-of-concept randomized trial.
Aran A; Harel M; Cassuto H; Polyansky L; Schnapp A; Wattad N; Shmueli D; Golan D; Castellanos FX
Mol Autism; 2021 Feb; 12(1):6. PubMed ID: 33536055
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
Poleg S; Golubchik P; Offen D; Weizman A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():90-96. PubMed ID: 30171992
[TBL] [Abstract][Full Text] [Related]
8. Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders.
Duvall SW; Lindly O; Zuckerman K; Msall ME; Weddle M
Pediatrics; 2019 Feb; 143(2):. PubMed ID: 30610100
[TBL] [Abstract][Full Text] [Related]
9. Autism Spectrum Disorder and Medical Cannabis: Review and Clinical Experience.
Mostafavi M; Gaitanis J
Semin Pediatr Neurol; 2020 Oct; 35():100833. PubMed ID: 32892960
[TBL] [Abstract][Full Text] [Related]
10. Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and Efficacy.
Bar-Lev Schleider L; Mechoulam R; Saban N; Meiri G; Novack V
Sci Rep; 2019 Jan; 9(1):200. PubMed ID: 30655581
[TBL] [Abstract][Full Text] [Related]
11. Behavioral aspects and neurobiological properties underlying medical cannabis treatment in Shank3 mouse model of autism spectrum disorder.
Poleg S; Kourieh E; Ruban A; Shapira G; Shomron N; Barak B; Offen D
Transl Psychiatry; 2021 Oct; 11(1):524. PubMed ID: 34645786
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid treatment for the symptoms of autism spectrum disorder.
Aran A; Cayam Rand D
Expert Opin Emerg Drugs; 2024 Mar; 29(1):65-79. PubMed ID: 38226593
[TBL] [Abstract][Full Text] [Related]
13. The Potential of Salivary Lipid-Based Cannabis-Responsive Biomarkers to Evaluate Medical Cannabis Treatment in Children with Autism Spectrum Disorder.
Siani-Rose M; McKee R; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
Cannabis Cannabinoid Res; 2023 Aug; 8(4):642-656. PubMed ID: 35343818
[No Abstract] [Full Text] [Related]
14. Pharmacological management of behavioral disturbances in children and adolescents with autism spectrum disorders.
Lamy M; Erickson CA
Curr Probl Pediatr Adolesc Health Care; 2018 Oct; 48(10):250-264. PubMed ID: 30262163
[TBL] [Abstract][Full Text] [Related]
15. A machine learning approach for understanding the metabolomics response of children with autism spectrum disorder to medical cannabis treatment.
Quillet JC; Siani-Rose M; McKee R; Goldstein B; Taylor M; Kurek I
Sci Rep; 2023 Aug; 13(1):13022. PubMed ID: 37608004
[TBL] [Abstract][Full Text] [Related]
16. Psychopharmacological interventions in autism spectrum disorder.
Accordino RE; Kidd C; Politte LC; Henry CA; McDougle CJ
Expert Opin Pharmacother; 2016; 17(7):937-52. PubMed ID: 26891879
[TBL] [Abstract][Full Text] [Related]
17. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.
Siani-Rose M; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
Cannabis Cannabinoid Res; 2023 Feb; 8(1):126-137. PubMed ID: 34874191
[No Abstract] [Full Text] [Related]
18. Medicinal Cannabis for Paediatric Developmental, Behavioural and Mental Health Disorders.
Efron D; Taylor K
Int J Environ Res Public Health; 2023 Apr; 20(8):. PubMed ID: 37107712
[TBL] [Abstract][Full Text] [Related]
19. Autism Spectrum Disorder: Classification, diagnosis and therapy.
Sharma SR; Gonda X; Tarazi FI
Pharmacol Ther; 2018 Oct; 190():91-104. PubMed ID: 29763648
[TBL] [Abstract][Full Text] [Related]
20. Symptoms, adverse events, and outcomes in the use of medicinal cannabis in children and adolescents with autism spectrum disorder: a scoping review protocol.
Fletcher S; Pawliuk C; Ip A; Oberlander T; Siden H
JBI Evid Synth; 2021 May; 19(5):1251-1258. PubMed ID: 33165173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
